Shanxi Bethune Hospital
Shanxi Bethune Hospital
Taiyuan, Shanxi, China26 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo | NonSegmental Vitiligo | Not yet recruiting | Phase 3 | 2026-10-08 | NCT07865312 | |
| Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2 | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-10-06 | NCT07263776 | |
| Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity . | Upper Limb Spasticity (ULS) | Recruiting | Phase 3 | 2026-09-23 | NCT07242300 | |
| Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 3 | 2026-09-17 | NCT07687459 | |
| To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 2 | 2026-09-17 | NCT07447986 | |
| Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature | cardiovascular disorder, peripheral vascular disease, vascular disorder | Recruiting | Not stated | 2026-09-15 | NCT04674969 | |
| Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Recruiting | Phase 3 | 2026-09-09 | NCT07711262 | |
| Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Recruiting | Phase 3 | 2026-09-03 | NCT07678931 | |
| A Study of BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer | HER2-positive Breast Cancer | Recruiting | Phase 2 / Phase 3 | 2026-08-26 | NCT06891833 | |
| A Study of E6742 in Participants With Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 2 | 2026-08-21 | NCT07515014 | |
| AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 2 | 2026-07-17 | NCT07712094 | |
| Clinical Study on the Effectiveness of Antibiotics Combined With Bifidobacterium Quadruple Live Tablets in Treating Cirrhosis With Spontaneous Bacterial Peritonitis and Preventing Recurrence | Cirrhosis With Spontaneous Bacterial Peritonitis | Not yet recruiting | Phase 4 | 2026-07-07 | NCT07686861 | |
| A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease | Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder | Active, not recruiting | Phase 3 | 2026-02-04 | NCT05662241 | |
| A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults | Upper Limb Spasticity | Recruiting | Phase 2 / Phase 3 | 2026-01-22 | NCT06783114 | |
| A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors | Advanced Solid Tumors; SCLC, Extensive Stage | Recruiting | Phase 2 | 2026-01-07 | NCT07321574 | |
| A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2025-12-18 | NCT07292714 | |
| A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-12-16 | NCT07189065 | |
| A Study of Telitacicept for IgA Nephropathy (TELIGAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 3 | 2025-12-16 | NCT05799287 | |
| F573 for Injection for the Treatment of Liver Injury/Failure | Acute-On-Chronic Liver Failure, Digestive System Diseases, Hepatic Insufficiency, acute liver failure, liver disorder, liver failure | Recruiting | Phase 2 | 2025-11-19 | NCT05689645 | |
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Not yet recruiting | Phase 3 | 2025-08-28 | NCT07146126 | |
| The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not applicable | 2025-08-22 | NCT07136025 | |
| The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not applicable | 2025-06-24 | NCT05618041 | |
| Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, blood platelet disease, connective tissue disorder, hematologic disorder, thrombocytopenia | Recruiting | Phase 2 | 2025-05-06 | NCT05998759 | |
| Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II) | Bacterial Infections and Mycoses, Infections, Pseudomonas infection, bacterial infectious disease, bronchial disorder, bronchiectasis, gram-negative bacterial infections, respiratory system disorder | Recruiting | Not stated | 2025-04-01 | NCT06760273 | |
| A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 4 | 2025-01-24 | NCT05058040 |